Skip to main content
. 2020 Oct 28;11:584642. doi: 10.3389/fendo.2020.584642

Table 3.

Overview of studies assessing the effects of home-based exercise programs in individuals with diabetes.

Study/population Home-based and comparator groups (N/age)/Follow-up Orientation, monitoring and follow-up Tools and measurements during home-based intervention Home-based exercise programs Home-based exercise improvements
Collins et al. (53) /T2DM+PAD Home-based: 37/35 (M/F)/66 ± 10 yr
Control: 53/20 (M/F)/67 ± 10 yr
Follow-up: 6 months
Orientation: 7-min educational video/orientation on self-management behaviors/instructional audiotape
Monitoring: phone calls (biweekly for 6 months)
Tools: pedometers and questionnaire
Measurements: diary (daily glucose, lipid, weekly blood pressures)
Frequency: 4-5 d/wk
Intensity: not reported
Time: 50 min/session
Type: aerobic (walking)
Walking speed; and quality of life
Dadgostar et al. (41) /T2DM Home-based: 36 (F)/49 ± 6 yr
Supervised exercise: 38 (F)/50± 5 yr
Follow-up: 3 months
Orientation: general information on diabetes, self-care, diet, and exercise (90min) + educational booklet
Monitoring: clinical visit (baseline, week 6 and week 12) + phone calls (biweekly for 6 weeks)
Tools: pedometers, elastic bands and activity log
Measurements: not reported
Frequency: 3-5 d/wk
Intensity: moderate (gradual progress from 2,500-30,00 to 10,000–12,000 steps per day)
Time: not reported
Type: aerobic (walking) and resistance (elastic bands)
Glycemic control; body composition; lipid profile; and health-related quality of life
Guelfi et al. (50) /Gestational DM Home-based: 85 (F)/34 ± 4 yr
Control: 87 (F)/34 ± 4 yr
Follow-up: 3 months
Orientation: not reported
Monitoring: supervision by an exercise physiologist at participants’ home (3 times-a-week)
Tools: HR monitor and RPE scale
Measurements: diary (daily nutritional intake)
Frequency: 3 d/week
Intensity: moderate (65-75% HRMAX) with intervals of high (75-85% HRMAX)
Time: 20-60 min/session (progressive)
Type: aerobic (cycle ergometer)
Cardiorespiratory fitness; exercise automaticity; and general psychological distress
Halse et al. (43) Gestational DM Home-based: 20 (F)/29 ± 1 yr
Control: 20 (F)/29 ± 1 yr
Follow-up: 8 months
Orientation: counseling by a diabetes educator and dietician
Monitoring: home visit
Tools: exercise diary and RPE scale
Measurements: capillary glucose, food diary and questionnaires
Frequency: 5 d/wk
Intensity: progressive - moderate- (65-75% HRMAX) to high-intensity interval (75-85% HRMAX)
Time: 25 to 45 min/session (progressive)
Type: aerobic (cycle ergometer)
Postprandial glycemic control; and post-exercise capillary glucose
Karjalainen et al. (55) /T2DM+CAD Home-based T2DM+CAD: 32/7 (M/F)/62 ± 5 yr
Home-based CAD:???? (32/12 (M/F)/62 ± 5 yr
Follow-up: 6 months
Orientation: not reported
Monitoring: contacted by a sports medicine specialist or physiotherapist (1 and 3 months)
Tools: accelerometer, HR monitor and exercise diary
Measurements: daily diary
Frequency: 5 d/wk
Intensity: 50-70% HRRESERVE (progressive)
Time: 60 min/session
Type: aerobic and resistance training
Cardiorespiratory fitness; and daily levels of high-intensity activity
Krousel-Wood et al. (46) /T2DM
  • Home-based: 37 (not reported)/57 ± 10 yr

Control: 39 (not reported)/57 ± 10 yr
  • Follow-up: 3 months

Orientation: education program on diabetes self-management (5 sessions, 2.5h)
Monitoring: clinic visit (1 per month up to 3rd month)
Tools: videotape exercise and activity logs
Measurements: questionnaires
Frequency: 5 d/w
Intensity: low- to moderate-intensity (3-6 METs)
Time: 30 min/session
Type: aerobic and resistance
Body mass index; and quality of life
Lee et al. (44) /T2DM
  • Home-based steps group: 19/21 (M/F)/54 ± 10 yr

  • Home-based aerobic group: 21/19 (M/F)/56 ± 8 yr

  • Control: 18/22 (M/F)/56 ± 9 yr

  • Follow-up: 3 months

Orientation: a nurse-oriented session on how to correctly perform the program
Monitoring: phone calls (weekly)
Tools: pedometer (steps group) or portable oximeter and RPE scale (aerobic group)
Measurements: not reported
Frequency: 5 d/wk
Intensity: moderate (13-15 RPE) or not reported (steps group)
Time: 10,000 steps/day (steps group) or 30 min/session (aerobic group)
Type: aerobic (steps group: walking; aerobic group: brisk walking, jogging and/or bicycling)
Glucose metabolism; and pancreatic beta cell function (greater improvements in the steps group)
Marios et al. (49)/T2DM
  • Tele-monitored home-based: 10/5 (M/F)/60 ± 9 yr

  • Non-monitored home-based (control): 4/9 (M/F)/65 ± 8 yr

  • Follow-up: 6 months

Orientation: not reported
Monitoring: phone calls (weekly)
Tools: HR monitor
Measurements: exercise training diary
Frequency: not reported
Intensity: not reported
Time: 180 min per week
Type: aerobic (walking program)
Cardiorespiratory fitness; and exercise tolerance
Olse et al. (45)/T2DM Home-based T2DM: 9 (M)/60± 2 yr
Home-based healthy control: 8 (M)/56 ± 1 yr
Follow-up: 2 months
Orientation: not reported
Orientation: regular phone calls
Tools: HR monitor
Measurements: exercise training diary
Frequency: 3-4 d/wk
Intensity: 65-70% VO2PEAK
Time: 30 min/session
Type: aerobic (rowing ergometer)
Submaximal aerobic capacity; and insulin‐mediated glucose extraction and clearance
Plotnikoff et al. (42) /T2DM Home-based: 8/19 (M/F)/55 ± 12 yr
Control: 8/13 (M/F)/54 ± 12 yr
Follow-up: 4 months
Orientation: one week of learning and practicing of each exercise by supervision of an exercise specialist
Monitoring: home visits (18 of 48 sessions) + clinical visits (week 2 and 10)
Tools: multigym apparatus and dumbbells
Measurements: exercise training logs
Frequency: 3 d/week
Intensity: moderate- (50-60% of 1RM) to high-intensity (70-85% of 1RM) - progressive
Time: not reported (2-3 sets of 8-12 reps in 8 exercises)
Type: resistance
Muscle strength; fasting insulin; HDL cholesterol; social-cognitive variables; and exercise self-efficacy
Scheede-Bergdahl et al. (52) /T2DM Home-based T2DM: 12 (M)/59 ± 2 yr
Home-based healthy control: 9 (M)/55 ± 1 yr
Follow-up: 2 months
Orientation: not reported
Monitoring: not reported
Tools: HR monitor
Measurements: training logs
Frequency: 3-4 d/wk
Intensity: 65-70% of VO2PEAK
Time: 30 min/session
Type: aerobic (rowing ergometer)
Submaximal aerobic capacity; and C-reactive protein
Shinji et al. (51) /T2DM Home-based high-compliance: 40/24 (M/F) 58 ± 10 yr
Home-based low-compliance: 21/17 (M/F)/54 ± 10 yr
Follow-up: 3/17 months of intervention/incidence of cardiovascular events
Orientation: diabetes education, health counseling and an exercise prescription
Monitoring: phone calls
Tools: not reported
Measurements: self-reported adherence
Frequency: 4-6 d/wk
Intensity: moderate (adjusted to anaerobic threshold)
Time: 20-30 min/session
Type: aerobic (walking)
Lower incidence of cardiovascular disease
Wu et al. (47) /at risk for T2DM Home-based: 22/46 (M/F)/54 ± 5 yr
Control: 16/51 (M/F)/54 ± 6 yr
Follow-up: 9 months
Orientation: educational orientation with a physiotherapist (1.5h), and guided book on proper diet and diabetes prevention
Monitoring: phone calls (weekly–biweekly intervals for 3 months, reducing from 3 to 6 months and ending after 6 months)
Tools: exercise video and stepper
Measurements: body weight, exercise training logs and questionnaires (physical activity, self-efficacy)
Frequency: 3-5 d/wk
Intensity: moderate to vigorous
Time: 30 min/session
Type: aerobic
Exercise self-efficacy; body mass index; muscle endurance; flexibility; and physical activity levels
Yang et al. (48) /T2DM Home-based: 274/309 (M/F)/58 ± 1 yr
Follow-up: 6 months
Orientation: education on diabetes management and healthy lifestyle behaviors
Monitoring: supervised session once-a-week
Tools: not reported
Measurements: exercise training diary
Frequency: 5 d/wk
Intensity: 60-75% of VO2PEAK or HRRESERVE
Time: not reported
Type: aerobic (walking) and resistance (free weights/elastic bands)
Cardiorespiratory fitness; and body mass index

CAD, coronary artery disease; DM, diabetes mellitus; F, female; HR, heart rate; M, male; PAD, peripheral arterial disease; RPE, rating of perceived exertion; T2DM, type 2 diabetes mellitus.